[{"address1": "5505 Endeavor Lane", "city": "Madison", "state": "WI", "zip": "53719", "country": "United States", "phone": "608 284 5700", "website": "https://www.exactsciences.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.", "fullTimeEmployees": 6500, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kevin T. Conroy", "age": 57, "title": "Chairman of The Board & CEO", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 3143663, "exercisedValue": 0, "unexercisedValue": 23814904}, {"maxAge": 1, "name": "Mr. Jake  Orville MBA", "age": 49, "title": "Executive VP & GM of Screening", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 1037212, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Baranick", "age": 45, "title": "Executive VP & General Manager of Precision Oncology", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 942890, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Aaron  Bloomer", "age": 37, "title": "Executive Vice President of Finance", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jorge A. Garces Ph.D.", "age": 51, "title": "Chief Science Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nassar  Nizami", "title": "Chief Information Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan  Jones", "title": "Associate Manager of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tim  Caprez", "title": "Chief Compliance Counsel & VP", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Herriott", "age": 43, "title": "Senior VP, General Counsel & Secretary", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Condella", "age": 42, "title": "Executive Vice President of Human Resources", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 742763, "exercisedValue": 0, "unexercisedValue": 844423}], "auditRisk": 4, "boardRisk": 4, "compensationRisk": 3, "shareHolderRightsRisk": 3, "overallRisk": 3, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://investor.exactsciences.com", "maxAge": 86400, "priceHint": 2, "previousClose": 70.26, "open": 69.79, "dayLow": 68.91, "dayHigh": 70.815, "regularMarketPreviousClose": 70.26, "regularMarketOpen": 69.79, "regularMarketDayLow": 68.91, "regularMarketDayHigh": 70.815, "beta": 1.273, "forwardPE": -1151.8334, "volume": 864851, "regularMarketVolume": 864851, "averageVolume": 2347268, "averageVolume10days": 1311820, "averageDailyVolume10Day": 1311820, "marketCap": 12983764992, "fiftyTwoWeekLow": 40.62, "fiftyTwoWeekHigh": 79.62, "priceToSalesTrailing12Months": 4.970793, "fiftyDayAverage": 65.7124, "twoHundredDayAverage": 58.78565, "currency": "USD", "enterpriseValue": 14606595072, "profitMargins": -0.067, "floatShares": 183437671, "sharesOutstanding": 184770000, "sharesShort": 15538863, "sharesShortPriorMonth": 16419544, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0841, "heldPercentInsiders": 0.01002, "heldPercentInstitutions": 1.04647, "shortRatio": 7.38, "shortPercentOfFloat": 0.0849, "impliedSharesOutstanding": 187871008, "bookValue": 17.287, "priceToBook": 3.9978018, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -175008000, "trailingEps": -0.95, "forwardEps": -0.06, "pegRatio": -0.75, "enterpriseToRevenue": 5.592, "enterpriseToEbitda": -211.994, "52WeekChange": 0.1701659, "SandP52WeekChange": 0.39389753, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "EXAS", "underlyingSymbol": "EXAS", "shortName": "Exact Sciences Corporation", "longName": "Exact Sciences Corporation", "firstTradeDateEpochUtc": 981037800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "cc64cb89-936d-3419-82bf-b1c20cc85a89", "messageBoardId": "finmb_28311", "gmtOffSetMilliseconds": -14400000, "currentPrice": 69.11, "targetHighPrice": 100.0, "targetLowPrice": 61.0, "targetMeanPrice": 79.06, "targetMedianPrice": 80.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 21, "totalCash": 946782016, "totalCashPerShare": 5.124, "ebitda": -68901000, "totalDebt": 2783931904, "quickRatio": 1.853, "currentRatio": 2.172, "totalRevenue": 2612011008, "debtToEquity": 87.206, "revenuePerShare": 14.343, "returnOnAssets": -0.02708, "returnOnEquity": -0.056009997, "freeCashflow": -574750, "operatingCashflow": 118664000, "revenueGrowth": 0.124, "grossMargins": 0.73188, "ebitdaMargins": -0.02638, "operatingMargins": -0.03133, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-28"}]